Skip to main content

MARSHALL WACE, LLP

Position in ATYR — aTYR PHARMA INC

CIK 1318757 LONDON, X0

Position in ATYR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$219,766
+$112,035 QoQ
Shares Held
368,120
+166.5% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 90 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ATYR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. ATYR ranks #241 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATYR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $219,766 368,120
2026-03-31 $107,731 138,118
2025-06-30 $2,592,858 511,412
2025-03-31 $2,532,124 838,452
2024-09-30 $24,694 14,031
2024-03-31 $309,307 158,619
2023-03-31 $22,988 10,947
2022-12-31 $307,248 140,296
2022-09-30 $527,730 175,910
2022-06-30 $451,121 159,407
2022-03-31 $1,086,087 203,007
2021-12-31 $1,870,458 250,396
2021-09-30 $390,494 43,006